# Waystar Holding Corp.: financial statements, quarterly

WAY · Nasdaq · CIK 1990354 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/way.md) · [Financials](/companies/way/financials.md) · [Filings](/companies/way/filings.md) · [Insiders](/companies/way/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/way/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [197](/filings/0001410578-24-001768.md) | [207 d](/filings/0001990354-26-000011.md) | [225](/filings/0001410578-25-001048.md) | [235](/filings/0001990354-25-000012.md) | [240](/filings/0001990354-25-000031.md) | [244 d](/filings/0001990354-26-000011.md) | [256](/filings/0001990354-26-000025.md) | [271](/filings/0001990354-26-000035.md) | [269](/filings/0001990354-25-000031.md) | [304 d](/filings/0001990354-26-000011.md) | [314](/filings/0001990354-26-000025.md) | [320](/filings/0001990354-26-000035.md) |
| Research and development | $m | [9.0](/filings/0001410578-24-001768.md) | [9.8 d](/filings/0001990354-26-000011.md) | [10.3](/filings/0001410578-25-001048.md) | [15.9](/filings/0001990354-25-000012.md) | [11.1](/filings/0001990354-25-000031.md) | [11.5 d](/filings/0001990354-26-000011.md) | [11.1](/filings/0001990354-26-000025.md) | [12.6](/filings/0001990354-26-000035.md) | [12.4](/filings/0001990354-25-000031.md) | [18.5 d](/filings/0001990354-26-000011.md) | [18.4](/filings/0001990354-26-000025.md) | [17.7](/filings/0001990354-26-000035.md) |
| Operating income | $m | [32.2](/filings/0001410578-24-001768.md) | [37.7 d](/filings/0001990354-26-000011.md) | [35.2](/filings/0001410578-25-001048.md) | [8.2](/filings/0001990354-25-000012.md) | [27.1](/filings/0001990354-25-000031.md) | [53.1 d](/filings/0001990354-26-000011.md) | [65.2](/filings/0001990354-26-000025.md) | [64.8](/filings/0001990354-26-000035.md) | [60.2](/filings/0001990354-25-000031.md) | [59.0 d](/filings/0001990354-26-000011.md) | [80.5](/filings/0001990354-26-000025.md) | [76.0](/filings/0001990354-26-000035.md) |
| Interest expense | $m | not reported | not reported | not reported | [50.5](/filings/0001990354-25-000012.md) | [18.5](/filings/0001990354-25-000031.md) | not reported | [18.9](/filings/0001990354-26-000025.md) | [18.3](/filings/0001990354-26-000035.md) | [17.5](/filings/0001990354-25-000031.md) | not reported | [20.6](/filings/0001990354-26-000025.md) | [19.6](/filings/0001990354-26-000035.md) |
| Income tax | $m | [(4.7)](/filings/0001410578-24-001768.md) | [(0.8) d](/filings/0001990354-26-000011.md) | [(6.1)](/filings/0001410578-25-001048.md) | [(14.6)](/filings/0001990354-25-000012.md) | [3.3](/filings/0001990354-25-000031.md) | [14.0 d](/filings/0001990354-26-000011.md) | [17.0](/filings/0001990354-26-000025.md) | [14.4](/filings/0001990354-26-000035.md) | [12.1](/filings/0001990354-25-000031.md) | [16.2 d](/filings/0001990354-26-000011.md) | [16.5](/filings/0001990354-26-000025.md) | [15.5](/filings/0001990354-26-000035.md) |
| Net income | $m | [(15.5)](/filings/0001410578-24-001768.md) | [(14.4) d](/filings/0001990354-26-000011.md) | [(15.9)](/filings/0001410578-25-001048.md) | [(27.7)](/filings/0001990354-25-000012.md) | [5.4](/filings/0001990354-25-000031.md) | [19.1 d](/filings/0001990354-26-000011.md) | [29.3](/filings/0001990354-26-000025.md) | [32.2](/filings/0001990354-26-000035.md) | [30.6](/filings/0001990354-25-000031.md) | [20.0 d](/filings/0001990354-26-000011.md) | [43.3](/filings/0001990354-26-000025.md) | [40.9](/filings/0001990354-26-000035.md) |
| Diluted EPS | $ per share | [(0.13)](/filings/0001410578-24-001768.md) | not reported | [(0.13)](/filings/0001410578-25-001048.md) | [(0.21)](/filings/0001990354-25-000012.md) | [0.03](/filings/0001990354-25-000031.md) | not reported | [0.16](/filings/0001990354-26-000025.md) | [0.18](/filings/0001990354-26-000035.md) | [0.17](/filings/0001990354-25-000031.md) | not reported | [0.22](/filings/0001990354-26-000025.md) | [0.21](/filings/0001990354-26-000035.md) |
| Basic EPS | $ per share | [(0.13)](/filings/0001410578-24-001768.md) | not reported | [(0.13)](/filings/0001410578-25-001048.md) | [(0.21)](/filings/0001990354-25-000012.md) | [0.03](/filings/0001990354-25-000031.md) | not reported | [0.17](/filings/0001990354-26-000025.md) | [0.19](/filings/0001990354-26-000035.md) | [0.18](/filings/0001990354-25-000031.md) | not reported | [0.23](/filings/0001990354-26-000025.md) | [0.21](/filings/0001990354-26-000035.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [44.5](/filings/0001410578-24-001768.md) | [35.6](/filings/0001990354-26-000011.md) | [57.3](/filings/0001410578-25-001048.md) | [68.4](/filings/0001990354-25-000012.md) | [127](/filings/0001990354-25-000031.md) | [182](/filings/0001990354-26-000011.md) | [224](/filings/0001990354-26-000025.md) | [290](/filings/0001990354-26-000035.md) | [421](/filings/0001990354-25-000031.md) | [61.4](/filings/0001990354-26-000035.md) | [34.3](/filings/0001990354-26-000025.md) | [12.6](/filings/0001990354-26-000035.md) |
| Current assets | $m | not reported | [222](/filings/0001410578-25-000148.md) | not reported | [271](/filings/0001410578-24-001168.md) | [305](/filings/0001410578-24-001768.md) | [371](/filings/0001990354-26-000011.md) | [441](/filings/0001410578-25-001048.md) | [524](/filings/0001990354-25-000012.md) | [614](/filings/0001990354-25-000031.md) | [308](/filings/0001990354-26-000035.md) | [387](/filings/0001990354-26-000025.md) | [439](/filings/0001990354-26-000035.md) |
| Total assets | $m | not reported | [4,583](/filings/0001410578-25-000148.md) | not reported | [4,567](/filings/0001410578-24-001168.md) | [4,541](/filings/0001410578-24-001768.md) | [4,577](/filings/0001990354-26-000011.md) | [4,619](/filings/0001410578-25-001048.md) | [4,678](/filings/0001990354-25-000012.md) | [4,746](/filings/0001990354-25-000031.md) | [5,785](/filings/0001990354-26-000035.md) | [5,839](/filings/0001990354-26-000025.md) | [5,869](/filings/0001990354-26-000035.md) |
| Current liabilities | $m | not reported | [123](/filings/0001410578-25-000148.md) | not reported | [126](/filings/0001410578-24-001168.md) | [133](/filings/0001410578-24-001768.md) | [146](/filings/0001990354-26-000011.md) | [141](/filings/0001410578-25-001048.md) | [153](/filings/0001990354-25-000012.md) | [158](/filings/0001990354-25-000031.md) | [218](/filings/0001990354-26-000035.md) | [220](/filings/0001990354-26-000025.md) | [238](/filings/0001990354-26-000035.md) |
| Total liabilities | $m | not reported | [2,533](/filings/0001410578-25-000148.md) | not reported | [1,621](/filings/0001410578-24-001168.md) | [1,488](/filings/0001410578-24-001768.md) | [1,497](/filings/0001990354-26-000011.md) | [1,493](/filings/0001410578-25-001048.md) | [1,505](/filings/0001990354-25-000012.md) | [1,524](/filings/0001990354-25-000031.md) | [1,906](/filings/0001990354-26-000035.md) | [1,902](/filings/0001990354-26-000025.md) | [1,883](/filings/0001990354-26-000035.md) |
| Long-term debt | $m | not reported | [2,200](/filings/0001410578-25-000148.md) | not reported | [1,334](/filings/0001410578-24-001168.md) | [1,222](/filings/0001410578-24-001768.md) | [1,221](/filings/0001990354-26-000011.md) | [1,218](/filings/0001410578-25-001048.md) | [1,216](/filings/0001990354-25-000012.md) | [1,214](/filings/0001990354-25-000031.md) | [1,459](/filings/0001990354-26-000035.md) | [1,456](/filings/0001990354-26-000025.md) | [1,453](/filings/0001990354-26-000035.md) |
| Current portion of debt | $m | not reported | [18.0](/filings/0001410578-25-000148.md) | not reported | [12.9](/filings/0001410578-24-001168.md) | [12.9](/filings/0001410578-24-001768.md) | [11.7](/filings/0001990354-26-000011.md) | [11.7](/filings/0001410578-25-001048.md) | [11.7](/filings/0001990354-25-000012.md) | [11.7](/filings/0001990354-25-000031.md) | [14.2](/filings/0001990354-26-000035.md) | [14.2](/filings/0001990354-26-000025.md) | [14.2](/filings/0001990354-26-000035.md) |
| Shareholders' equity | $m | [2,074](/filings/0001410578-24-001768.md) | [2,050](/filings/0001990354-26-000011.md) | [2,035](/filings/0001990354-25-000012.md) | [2,946](/filings/0001990354-25-000031.md) | [3,053](/filings/0001990354-25-000031.md) | [3,080](/filings/0001990354-26-000035.md) | [3,126](/filings/0001990354-26-000035.md) | [3,173](/filings/0001990354-26-000035.md) | [3,223](/filings/0001990354-25-000031.md) | [3,879](/filings/0001990354-26-000035.md) | [3,937](/filings/0001990354-26-000035.md) | [3,986](/filings/0001990354-26-000035.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(10.4) d](/filings/0001410578-24-001768.md) | [11.5 d](/filings/0001990354-26-000011.md) | [10.7](/filings/0001410578-25-001048.md) | [15.5 d](/filings/0001990354-25-000012.md) | [78.8 d](/filings/0001990354-25-000031.md) | [64.8 d](/filings/0001990354-26-000011.md) | [64.2](/filings/0001990354-26-000025.md) | [96.8 d](/filings/0001990354-26-000035.md) | [82.0 d](/filings/0001990354-25-000031.md) | [66.6 d](/filings/0001990354-26-000011.md) | [84.9](/filings/0001990354-26-000025.md) | [59.4 d](/filings/0001990354-26-000035.md) |
| Capital expenditure | $m | [6.2 d](/filings/0001410578-24-001768.md) | [5.8 d](/filings/0001990354-26-000011.md) | [5.6](/filings/0001410578-25-001048.md) | [6.9 d](/filings/0001990354-25-000012.md) | [8.6 d](/filings/0001990354-25-000031.md) | [6.2 d](/filings/0001990354-26-000011.md) | [5.4](/filings/0001990354-26-000025.md) | [5.8 d](/filings/0001990354-26-000035.md) | [5.9 d](/filings/0001990354-25-000031.md) | [9.4 d](/filings/0001990354-26-000011.md) | [15.3](/filings/0001990354-26-000025.md) | [16.1 d](/filings/0001990354-26-000035.md) |
| Share repurchases | $m | [0.0 d](/filings/0001410578-24-001768.md) | [0.0 d](/filings/0001990354-26-000011.md) | [0.2](/filings/0001410578-25-001048.md) | [0.6 d](/filings/0001990354-25-000012.md) | [0.0 d](/filings/0001990354-25-000031.md) | [0.0 d](/filings/0001990354-26-000011.md) | not reported | not reported | [0.0 d](/filings/0001990354-25-000031.md) | [0.0 d](/filings/0001990354-26-000011.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2023-06-30) | period not labelled (2023-09-30) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [122](/filings/0001410578-24-001168.md) | [122](/filings/0001410578-24-001768.md) | [122](/filings/0001410578-25-001048.md) | [134](/filings/0001990354-25-000012.md) | [176](/filings/0001990354-25-000031.md) | [181](/filings/0001990354-26-000025.md) | [182](/filings/0001990354-26-000035.md) | [181](/filings/0001990354-25-000031.md) | [195](/filings/0001990354-26-000025.md) | [195](/filings/0001990354-26-000035.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 191,748,416 at 2026-07-23, from the cover of the [10-Q filed 2026-07-29](/filings/0001990354-26-000035.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.